Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders

C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders

US Patent 9228189 · Granted Jan 5, 2016

Estimated economic value: $10,393,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

GalNAc derivatives2025
Modified nucleoside phosphoramidites2025
Guanine analogs as telomerase substrates and telomere length affectors2025
Guanine analogs as telomerase substrates and telomere length affectors2025
Modified oligonucleotides and methods of use2024
Treatment of drug resistant proliferative diseases with telomerase mediated telo2024
Modified nucleoside phosphoramidites2024
Multivalent delivery of immune modulators by liposomal spherical nucleic acids f2024
Liposomal particles, methods of making same and uses thereof2024
Modified oligonucleotides for use in treatment of tauopathies2022
Guanine analogs as telomerase substrates and telomere length affectors2022
Guanine analogs as telomerase substrates and telomere length affectors2022